Patterns and Outcomes of Subsequent Therapy After Immune Checkpoint Inhibitor Discontinuation in HCC
| dc.contributor.author | Muzaffar, Mahvish | |
| dc.contributor.author | Bulumulle, Anushi | |
| dc.contributor.author | Sharma, Rohini | |
| dc.date.accessioned | 2022-12-05T19:47:00Z | |
| dc.date.available | 2022-12-05T19:47:00Z | |
| dc.date.issued | 2022 | |
| dc.identifier.doi | 10.1002/hep4.1927 | |
| dc.identifier.issn | 2471-254X | |
| dc.identifier.uri | http://hdl.handle.net/10342/11818 | |
| dc.language.iso | en_US | en_US |
| dc.subject | immune checkpoint inhibitors (ICIs) | en_US |
| dc.subject | hepatocellular cancer (HCC) | en_US |
| dc.subject | tyrosine kinase inhibitors (TKIs) | en_US |
| dc.title | Patterns and Outcomes of Subsequent Therapy After Immune Checkpoint Inhibitor Discontinuation in HCC | en_US |
| dc.type | Article | en_US |
| ecu.journal.issue | 7 | en_US |
| ecu.journal.name | Hepatology Communications | en_US |
| ecu.journal.pages | 1776-1785 | en_US |
| ecu.journal.volume | 6 | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- MuzaffarPatternsandOutcomesofSubsequentTherapyAfterImmuneCheckpointInhibitorDiscontinuation.pdf
- Size:
- 580.5 KB
- Format:
- Adobe Portable Document Format
- Description: